Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Narrative (Details)

v3.25.0.1
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Contingency [Line Items]      
Deferred tax assets, valuation allowance $ 13,032,619 $ 10,774,128  
Net operating loss carryforwards $ 12,500,000 $ 13,400,000  
Effective tax rate (4.20%) 4339.90%  
Uncertain tax positions $ 900,000 $ 1,200,000  
Unrecognized tax benefits that if recognized would affect the annual effective tax rate 22,078 19,433  
Accrued interest and penalties 201,746 142,213  
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics      
Income Tax Contingency [Line Items]      
Deferred tax assets attributable to VIEs 1,087,204 0  
Deferred tax assets attributable to VIEs   1,088,801  
Uncertain tax positions 948,182 1,175,766 $ 1,314,351
Research Tax Credit Carryforward      
Income Tax Contingency [Line Items]      
Tax credits 14,229    
California Alternative Minimum Tax Credit      
Income Tax Contingency [Line Items]      
Tax credits 21,621    
Domestic Tax Jurisdiction      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 2,600,000 $ 2,800,000  
Net operating losses 8,200,000    
Net operating losses with an indefinite carryforward $ 4,300,000